127 results
Page 2 of 7
S-4
ruqjexur
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-99.1
fdskryomy1f98pnr de
8 Nov 22
Adaptimmune Reports Third-Quarter Financial Results and Business Update
7:42am
8-K
agbl0857 v2wxhjg2
25 Oct 22
Adaptimmune Enhances its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK
8:10am
8-K
EX-99.1
bvlcv1hn
25 Oct 22
Adaptimmune Enhances its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK
8:10am
424B5
in47glg7
28 Apr 22
Prospectus supplement for primary offering
8:09am
8-K
EX-99.1
9nk57jzb7wme427n yq
14 Mar 22
Adaptimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
8:06am
8-K
EX-10.01
ldu v47vn
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-99.1
3bnnh4m
12 Nov 21
Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS
6:30am
8-K
EX-99.1
ofmjie3b j5hzk3
4 Nov 21
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:40am